Mechanism of alpha-synuclein oligomerization and membrane interaction: theoretical approach to unstructured proteins studies

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 4, Issue 4, 2008, Pages 350-357

  Tsigelny, Igor F ^a,b   Sharikov, Yuriy ^b   Miller, Mark A ^b   Masliah, Eliezer ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

synuclein: Molecular dynamics; Parkinson's disease; Unstructured proteins

Indexed keywords

AGGLOMERATION; DYNAMICS; FLOW INTERACTIONS; MOLECULAR DYNAMICS; OLIGOMERIZATION; QUANTUM CHEMISTRY;

ALZHEIMER'S DISEASES; BIO-CHEMICALS; ELECTROPHYSIOLOGICAL STUDIES; HUNTINGTON'S DISEASES; MEMBRANE INTERACTIONS; MISFOLDING; MOLECULAR EVENTS; MOLECULAR MECHANISMS; NEURODEGENERATION; NEURODEGENERATIVE DISORDERS; PARKINSON'S DISEASE; PARKINSON'S DISEASES; SYNUCLEIN; SYNUCLEIN AGGREGATIONS; UNSTRUCTURED PROTEINS;

PROTEINS;

ALPHA SYNUCLEIN;

ARTICLE; BIOCHEMISTRY; DISEASE COURSE; ELECTROPHYSIOLOGY; HUMAN; HUMAN CELL; NERVE DEGENERATION; OLIGOMERIZATION; PARKINSON DISEASE; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN ASSEMBLY; PROTEIN CONFORMATION; PROTEIN INTERACTION; PROTEIN STRUCTURE;

ALPHA-SYNUCLEIN; CELL MEMBRANE; COMPUTER SIMULATION; DIMERIZATION; MODELS, MOLECULAR; PARKINSON DISEASE; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN STRUCTURE, SECONDARY;

EID: 55949104903     PISSN: 15499634     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nano.2008.05.005     Document Type: Article

References (28)

1. Kransnoslobodtsev A.V., Shlyakhtenko L.S., Ukraintsev E., Zaikova T.O., Keana J.F., and Lyubchenko Y.L. Nanomedicine and protein misfolding diseases. Nanomedicine 1 (2005) 300-305
2. Jellinger K.A. Neuropathological aspects of Alzheimer disease, Parkinson disease and frontotemporal dementia. Neurodegener Dis 5 (2008) 118-121
3. Shewmaker F., Ross E.D., Tycko R., and Wickner R.B. Amyloids of shuffled prion domains that form prions have a parallel in-register beta-sheet structure. Biochemistry 47 (2008) 4000-4007
4. Top 500 supercomputer sites [homepage on the Internet]. Top500org, c2000-2007 [updated 2007]. Available from: http://www.top500.org/.
5. Phillips J.C., Zheng G., Kumar S., and Kale L.V. NAMD: Biomolecular simulation on thousands of processors. Proceedings of the 2002 ACM/IEEE Conference on Supercomputing, Baltimore, Maryland, September 2002. Los Alamitos, California: IEEE Computer Society Press (2002)
6. Bertoncini C., Jung Y., Fernandez C., Hoyer W., Griesinge C., Jovin T., et al. Release of long-range tertiary interactions potentiates aggregation of natively unstructured α-synuclein. Proc Natl Acad Sci U S A 102 (2005) 1430-1435
7. Polymeropoulos M., Higgins J., and Golbe L.S. Mapping of a gene for Parkinson's disease to chromosome 4q21-q23. Science 274 (1996) 1197-1199
8. Glasera C.B., Yamin G., Vladimirm N., Uversky V.N., and Fink A.L. Methionine oxidation, alpha-synuclein and Parkinson's disease. Biochim Biophy Acta 1703 (2005) 157-169
9. Ibáñez P., Bonnet A.M., Débarges B., Lohmann E., Tison F., Pollak P., et al. Causal relation between alpha-synuclein gene duplication and familial Parkinson's disease. Lancet 364 (2004) 1169-1171
10. Moore D., West A., Dawson W., and Dawson T.M. Molecular pathophysiology of Parkinson's disease. Annu Rev Neurosci 28 (2005) 57-87
11. Ulmer T., Bax A., Cole N., and Nussbaum R. Structure and dynamics of micelle-bound human alpha-synuclein. J Biol Chem 280 (2005) 9595-9603
12. Davidson W., Jonas A., Clayton D., and George J. Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes. J Biol Chem 273 (1998) 9443-9449
13. Uversky V., Lee H., Li J., Fink A., and Lee S. Stabilization of partially folded conformation during alpha-synuclein oligomerization in both purified and cytosolic preparations. J Biol Chem 276 (2001) 43495-43498
14. Uversky V. A protein-chameleon: conformational plasticity of alpha-synuclein, a disordered protein involved in neurodegenerative disorders. J Biomol Struct Dyn 21 (2003) 211-234
15. Volles M., and Lansbury P.J. Zeroing in on the pathogenic form of alpha-synuclein and its mechanism of neurotoxicity in Parkinson's disease. Biochemistry 42 (2003) 7871-7878
16. Henriques S.T., Quintas A., Bagatolli L.A., Homblé F., and Castanho M.A. Energy-independent translocation of cell-penetrating peptides occurs without formation of pores. A biophysical study with pep-1. Mol Membr Biol 24 (2007) 282-293
17. Glabe C.G. Common mechanisms of amyloid oligomer pathogenesis in degenerative disease. Neurobiol Aging 27 (2006) 570-575
18. Kalé L., Skeel R., Bhandarkar M., Brunner R., Gursoy A., Krawetz N., et al. NAMD2: greater scalability for parallel molecular dynamics. J Comp Physics 151 (1999) 282-312
19. Feller S., and MacKerell A. An improved empirical potential energy function for molecular simulations of phospholipids. J Phys Chem B 104 (2000) 7510-7515
20. Gao M., and Schulten K. Onset of anthrax toxin pore formation. Biophys J 90 (2006) 3267-3279
21. Shindyalov I.N., and Bourne P.E. A database and tools for 3-D protein structure comparison and alignment using the Combinatorial Extension (CE) algorithm. Nucleic Acids Res 29 (2001) 228-229
22. Sharikov Y., Walker R.C., Greenberg J., Kouznetsova V., Nigam S., Miller M.A., et al. MAPAS: a tool for predicting membrane-contacting protein surfaces. Nat|Methods 5 (2008) 119
23. Law D.S., Ten Eyck L.F., Katzenelson O., Tsigelny I., Roberts V.A., Pique M.E., et al. Finding needles in haystacks: reranking DOT results by using shape complementarity, cluster analysis, and biological information. Proteins 52 (2003) 33-40
24. Ritchie D.W., and Kemp G.J.L. Protein docking using spherical polar Fourier correlations. Proteins 39 (2000) 178-194
25. Weaver T.M. The pi-helix translates structure into function. Protein Sci 9 (2000) 201-206
26. Flock D., Colacino S., Giorgio C., and Di Nola A. Misfolding of the amyloid beta protein: a molecular dynamics study. Proteins 62 (2006) 183-192
27. Tsigelny I.F., Bar-On P., Sharikov Y., Crews L., Hashimoto M., Miller M.A., et al. Dynamics of alpha-synuclein aggregation and inhibition of pore-like oligomer development by beta-synuclein. FEBS J 274 (2007) 1862-1877
28. Furukawa K., Matsuzaki-Kobayashi M., Hasegawa T., Kikuchi A., Sugeno N., Itoyama Y., et al. Plasma membrane ion permeability induced by mutant alpha-synuclein contributes to the degeneration of neural cells. J Neurochem 97 (2006) 1071-1077